The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Platinum), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Welcome to The Mantle Cell Lymphoma (MCL) Channel
VJHemOnc brings you key updates in the field of mantle cell lymphoma (MCL) directly from leading researchers. The Mantle Cell Lymphoma Channel covers all of the pivotal updates in MCL presented at major international congresses so that you can stay up-to-date through video interviews, podcasts and roundtable discussions with leading experts.
Explore The Mantle Cell Lymphoma Channel to learn about state-of-the-art research and investigations exploring new and exciting therapies for the treatment of MCL, including immunomodulators, proteasome inhibitors, monoclonal antibodies and CAR-T cell therapies. As well as key trial updates, The Mantle Cell Lymphoma Channel also covers areas including transplantation and asks questions about optimizing therapy sequencing and managing treatment-related toxicities.
Sorry, no posts matched your criteria.
The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Platinum), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Platinum Supporter
Gold Supporter
Silver Supporter
Bronze Supporter
If you are interested in becoming a supporter of The Lymphoma Channel, please contact us.
